A New Stake in Evolv: Promise and Peril

The fund, in its quarterly report, disclosed the purchase of 1,511,866 shares, a gesture both bold and hesitant. The value of this holding, 7.47% of the fund’s equity assets, suggested a calculated risk, yet the numbers themselves were a riddle: a company with a market cap of nearly a billion, yet net income in the red, its revenues a flickering flame.






